Clinical Trial: A Study of the Pharmacokinetics and Safety of CS0159 in Subjects With Hepatic Injury

U.S., March 22 -- ClinicalTrials.gov registry received information related to the study (NCT06888115) titled 'A Study of the Pharmacokinetics and Safety of CS0159 in Subjects With Hepatic Injury' on March 05.

Brief Summary: Phase I Study of the Pharmacokinetics and Safety of CS0159 in Subjects With Hepatic Injury

Study Start Date: March 12

Study Type: INTERVENTIONAL

Condition: Primary Biliary Cholangitis

Intervention: DRUG: CS0159

Single oral dose of CS0159 4mg

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Cascade Pharmaceuticals, Inc

Published by HT Digital Content Services with permission from Health Daily Digest....